Skip to content
‹ Back to IndustriesSciences

What AI Means for Future Scientists

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly. History shows that technology does indeed change the nature of work. Perhaps the most dramatic example of this was the industrial revolution during the late 18th and…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Samuel Miller · · AiArtificial IntelligenceAutomationHuman Jobs
Share
What AI Means for Future Scientists

Key takeaways

01

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly.

02

History shows that technology does indeed change the nature of work.

03

Perhaps the most dramatic example of this was the industrial revolution during the late 18th and…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

It is a cry that has been repeated for centuries now— ‘technology will take my job.’ This is a sentiment that is certainly not to be taken lightly. History shows that technology does indeed change the nature of work. Perhaps the most dramatic example of this was the industrial revolution during the late 18th and early 19th centuries that saw Europe and America transform from agrarian states to mechanized giants powered by coal and whale oil.

A New Revolution?

Today a quieter but no less drastic shift is taking place as mobile technology, blockchain, and artificial intelligence (AI), among other digital technologies, change the nature of work for many. While a first reaction might be to worry for the safety of human jobs, it is more accurate to say that technology changes the nature of certain jobs.

For example, ATMs did not remove the job of the bank teller, it simply altered their primary role from dispensing cash, to opening accounts and other clerical tasks.

The AI Effect

Perhaps the most disruptive, and ethically vague, of these new technologies is AI. One big concern related to AI is how it will affect jobs that require advanced quantitative skills, such as those in the scientific fields. Obviously, the scientific fields encompass a great deal of jobs requiring an equally diverse set of skills and qualifications. For the purposes of this article, we are discussing jobs that require higher degree such as an MS/Ph.D, or a medical qualification such as an MD.

Beginning with the assumption that these types of jobs are more at risk of artificial intelligence automation. Jobs in scientific fields are by and large more quantitative than their counterparts in the humanities or social sciences. Quantitative work is often formulaic by nature, and therefore capable of being done by highly-intelligent computers. Certain lab processes such as component testing are already being done by machines.

However, many scientific fields also require highly specific kinds of qualitative and ethical reasoning as well. This can most easily be seen in the medical fields, where a certain amount of humanity is required to diagnose and understand medical tests.

What it Means for Science

A recent article published by a career radiologist for The Scientist magazine highlights the delicate human decisions he must make every day, decisions that, at least currently, artificial intelligence is incapable of making. He demonstrates how AI is very good at identifying the fact based “what” questions, but not the judgement based “why’s.”

These are insights based on human experience and understanding that are incredibly difficult if not impossible to program. This is the human strength of the sciences and leveraging, cultivating this advantage should become a priority for educators and institutions in the near future.

Emphasizing the human side of the sciences and making it a bigger part of the field, will help prevent AI from automating science field jobs. And it is not just the sciences; Re-discovering the humanities has been a growing movement in areas such as business as well, where fields like ethical philosophy and creative design thinking have become popular to not just avoid automation, but to inject some meaning and, well, humanity into the field. At the end of the day, machines are not human and, at least for now, there are somethings that humans are just better at.

For the latest news, videos, and podcasts in the Science Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

SM
Samuel Miller
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

SM
Samuel Miller

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512